Drug Profile
Research programme: small molecule HIV entry inhibitors - ChemBridge Research Laboratories/Trimeris
Latest Information Update: 19 Mar 2008
Price :
$50
*
At a glance
- Originator ChemBridge Research Laboratories; Trimeris
- Class Small molecules
- Mechanism of Action Virus internalisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 20 Jun 2005 Preclinical trials in HIV infections treatment in USA (PO)